Sarepta names Michael Severino, former Tessera CEO, as new chief executive

Sarepta turns to Michael Severino as CEO, looking to move past recent turmoil

Michael Severino will replace the company’s longtime leader Doug Ingram on Tuesday. Severino joins from Flagship’s gene editing biotech Tessera Therapeutics, where he had been CEO since 2022.